Carregant...

Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease

Antibody deficiency is the most frequently encountered primary immunodeficiency disease (PIDD) and patients who lack the ability to make functional immunoglobulin require life-long replacement therapy to prevent serious bacterial infections. Human serum immunoglobulin manufactured from pools of dona...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Skoda-Smith, Suzanne, Torgerson, Troy R, Ochs, Hans D
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2817783/
https://ncbi.nlm.nih.gov/pubmed/20169031
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!